Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.
Biofourmis has raised $20.0M in total funding. The most recent round was Series D. The last funding was announced in July 2022.
Biofourmis's investors include General Atlantic, Sequoia Capital, Peak XV Partners, CVS Health, Intel Capital.
Biofourmis is headquartered in Boston, United States.
Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.
Biofourmis is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biofourmis — Funding & Investors." VCBacked, July 27, 2022, https://www.vcbacked.co/company/biofourmis. Accessed August 13, 2026.
VCBacked. (2022). Biofourmis — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/biofourmis
{{cite web |title=Biofourmis — Funding & Investors |url=https://www.vcbacked.co/company/biofourmis |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated